Abstract
In conclusion, mitral reconstruction via an annuloplasty ring effectively corrects mitral regurgitation in cardiomyopathy patients and is a safe procedure in a high-risk population with an acceptable operative mortality rate. Not only has survival in these patients improved but also functional status has changed remarkably. The effects of this procedure in patients with severe myocardial dysfunction may be attributed to a decrease in the regurgitant orifice area, improvement in the efficiency of each contraction with better effective forward flow, an increase in coronary flow reserve, and reversal of some the alterations in the neurohormonal changes seen in heart failure. These changes all contribute to restoration of the normal left ventricular geometric relationship. While longer-term follow-up is necessary with a greater number of patients, we are encouraged by these results and feel that mitral reconstruction offers a new strategy for end-stage cardiomyopathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, Ueda Y, Okada Y, Morioka S, Yoshikawa J (1998) Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery. J Am Coll Cardiol 32:1923–1930
Akins CW, Hilgenberg AD, Buckley MJ, Vlahakes GJ, Torchiana DF, Daggett WM, Austen WG (194) Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg 58:668–676
Alvarez JM, Deal CW, Loveridge K, Brennan P, Eisenberg R, Ward M, Bhattacharya K, Atkinson SJ, Choong C (1996) Repairing the degenerative mitral valve: ten to fifteen year follow-up. J Thorac Cardiovasc Surg 112:238–247
Anguita M, Arizon JM, Bueno G, Latre JM, Sancho M, Torres F, Gimenez D, Concha M, Valles F (1993) Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 72(5):413–417
Bach DS, Bolling SF (1996) Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol 78:966–969
Bach DS, Bolling SF (1995) Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 129:1165–1170
Batista R (1999) Partial left ventriculectomy - the Batista procedure. Eur J Cardio-Thorac Surg 15(Suppl 1):S12–S19
Batista RJ, Santos JL, Takeshita N, Bocchino L, Lima PN, Cunha MA (1996) Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 11(2):96–97
Batista RJV, Verde J, Nery P, Bocchino L, Takeshita N, Bhayana JN, Bergsland J, Graham S, Houck JP, Salerno TA (1997) Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 64:634–638
Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR (1991) Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 122(3 pt 1):763–771
Blum A, Miller H (1998) Role of cytokines in heart failure. Am Heart J 135(2 pt 1):181–186
Bohm M (1998) Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure. J Thorac Cardiovasc Surg 46(Suppl): 270–276
Bohm M (1995) Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem 147(1–2):1–2
Bohm M, Diet F, Kemkes B, Erdmann E (1998) Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heart. Klinische Wochenschrift 66(19):957–962
Bolling SF, Deeb GM, Brunsting LA, Bach DS (1995) Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 109(4):676–683
Bolling SF, Pagani FD, Deeb GM, Bach SF (1998) Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115:381–388
Boltwood CM, Tei C, Wong M, Shah PM (1983) Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation. Circulation 68(3):498–508
Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DE, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 307:205–211
Brodde OE (1991) Beta 1- and Beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43(2):203–242
Chandraratna PA, Aronow WS (1981) Mitral valve ring in normal vs. dilated left ventricle. Cross-sectional echocardiographic study. Chest 79(2):151–154
Chen FY, Adams DH, Aranki SF, Collins JJ, Couper GS, Rizzo RJ, Cohn LH (1998) Mitral valve repair in cardiomyopathy. Circulation 98:124-127
David TE, Uden DE, Strauss HD (1983) The importance of the mitral apparatus in left ventriuclar function after correction of mitral regurgitation. Circulation 68(3 pt 2):I176–1182
Dowling RD, Koenig S, Laureano A, Cerrito P, Gray LA (1998) Results of partial left ventriculectomy in patients with end-stage idiopathic dilated cardiomyopathy. J Heart Lung Transplant 17:1208–1212
Dreyfus GD, Duboc D, Blasco A, Vigoni F, Dubois C, Brodaty D, deLentdecker P, Bachet J, Goudot B, Guilmet D (1994) Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 57:1402–1408
Fann JI, Ingels NB, Miller DC (1997) Pathophysiology of mitral valve disease and operative indications. In: Edmunds LH (ed) Cardiac Surgery in the Adult. McGraw-Hill, NY, pp 959–990
Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75(2):331–339
Ferrari R, Bachetti T, Confortini R, Opasich C, Febo 0, Corti A, Cassani G, Visioli 0 (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92(6):1479–1486
Frazier OH (1994) First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation 89(6):2908–2914
Gallino A, Jenni R, Hurni R, Hirzel HO, Krayenbuhl HP, Egloff L, Rothlin M, Schonbeck M, Turina M (1987) Early results after mitral valvuloplasty for pure mitral regurgitation. Eur Heart J 8(8):902–905
Goldman ME, Mora F, Guarino T, Fuster V, Mindich BP (1987) Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two-dimensional echocardiographic study. J Am Coll Cardiol 10(3):568–575
Goldstein DJ, Oz MC, Rose EA (1998) Medical progress: implantable left ventricular assist devices. NEJM 339(21):1522–1533
Gorcsan J, Feldman AM, Kormos RL, Mandarino WA, Demetris AJ, Batista RJ (1998) Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance. Circulation 97(9):839–842
Hagewisch S, Weh HJ, Hossfeld DK (1990) TNF-induced cardiomyopathy. Lancet 335(8684):294–295
Harding SE, Brown LA, Wynne DG, Davies CH, Poole-Wilson PA (1994) Mechanisms of ß-adrenoceptor desensitization in the failing human heart. Cardiovasc Res 28:1451–1460
Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, Vooletich MT, Farmer JA, Torre-Amione G (1999) Tumor necrosis factor-a: A mediator of disease progression in the failing human heart. Chest 115:1170–1174
Huikuri HV (1983) Effect of mitral valve replacement on left ventricular function in mitral regurgitation. Br Heart J 49(4):328–333
Hunt SA (1998) Current status of cardiac transplantation. JAMA 280(19):1692–1698
Izumi S, Miyatake K, Beppu S, Park YD, Nagata S, Kinoshita N, Sakakibara H, Ni-mura Y (1987) Mechanism of mitral regurgitation in patients with myocardial infarction: a study using real-time two-dimensional Doppler flow imaging and echocardiography. Circulation 76(4):777–785
Juilliere Y, Danchin N, Briancon S, Khalife K, Ethevenot G, Balaud A, Gilgenkrantz JM, Pernot C, Cherrier F (1988) Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol 21(3):269–277
Kay GL, Kay JH, Zubiate P, Yokoyama T, Mendez M (1986) Mitral valve repair for mitral regurgitation secondary to coronary artery disease. Circulation 74(3 pt 2):188–198
Kawaguchi HK, Kitabatake A (1997) Alterations of signal transduction system in heart failure. Japan Heart J 38:317–332
Konertz W, Khoynezhad A, Sidiropoulos A, Borak V, Baumann G (1999) Early and intermediate results of left ventricular reduction surgery. Eur J Cardio-thorac Surg 15(Suppl 1): S26–S30
Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S (1992) Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 20(7):1594–1598
Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241
Magovern JA, Magovern GJ, Maher TD, Benckart DH, Park SB, Christlieb IY, Ma-govern GJ (1993) Operation for congestive heart failure: transplantation, coronary artery bypass, and cardiomyoplasty. Ann Thorac Surg 56:418–425
McCarthy JF, McCarthy PM, Starling RC, Smedira NG, Scalia GM, Wong J, Kasirajan V, Goormastic M, Young JB (1998) Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardio-thorac Surg 13:337–343
Milani RV, Mehra MR, Endres S, Eigler A, Cooper ES, Lavie CJ, Ventura HO (1996) The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest 110(4):992–995
Moreira LFP, Jatene AD (1991) Cardiomyoplasty in dilated cardiomyopathy. In: Carpentier A, Chachques JC, Grandjean PA (eds) Cardiomyoplasty. Futura, Armonk, NY, pp 171–183
Moreira LFP, Stolf NAG, Bocchi EA, Bacal F, Giorgi MC, Parga JR, Jatene AD (1998) Partial left ventriculectomy with mitral valve preservation in the treatment of patients with dilated cardiomyopathy. J Thorac Cardiovasc Surg 115:800–807
Nagatsu M, Ishihara K, Zile MR, Tsutsui H, Tagawa H, DeFreyte G, Tanaka R, Cooper G, Carabello BA (1994) The effects of complete versus incomplete mitral valve repair in experimental mitral regurgitation. J Thorac Cardiovasc Surg 107(2):416–423
Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS (1992) Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-a in conscious dogs. J Clin Invest 90:389–398
Pennington DG, Swartz MT, Lohmann DP, McBride LR (1998) Cardiac assist devices. Surgical Clinics of North America 78(5):691–704
Phillips HR, Levine FH, Carter JE, Boucher CA, Osbakken MD, Okada RD, Akins CW, Daggett WM, Buckley MJ, Pohost GM (1981) Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. Am J Cardiol 48(4):647–654
Pinson CW, Cobanoglu A, Metwdorff MT, Grunkemeier GL, Kay PH, Starr A (1984) Late surgical results for ischemic mitral regurgitation. Role of wall motion score and severity of regurgitation. J Thorac Cardiovasc Surg 88(5 pt 1):663–672
Pitarys CJ II, Forman MB, Panayiotou H, Hansen DE (1990) Long-term effects of excision of the mitral apparatus on global and regional ventricular function in humans. J Am Coll Cardiol 15(3):557–563
Rankin JS, Feneley MP, Hickey MS, Muhlbaier LH, Wchsler AS, Floyd RD, Reyes JG, Skelton TN, Califf RM, Lowe JE (1988) A clinical comparison of mitral valve repair versus replacement in ischemic mitral regurgitation. J Thorac Cadiovasc Surg 95(2):165–177
Rosario LB, Stevenson LW, Solomon SD, Lee RT, Reimold SC (1998) The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol 32:1819–1824
Salerno TA, Bhayana J (1997) Volume reduction surgery in the treatment of end-stage heart diseases. In: Karp RB, Laks H, Wechsler AS (eds) Advances in Cardiac Surgery, Vol 9. Mosby-Year Book, St. Louis, pp 87–97
Sarris GE, Cahill PD, Hansen DE, Derby GC, Miller DC (1988) Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J Thorac Cadiovasc Surg 95(6):969–979
Schuler G, Peterson KL, Johnson A, Francis G, Dennish G, Utley J, Daily PO, Ashburn W, Ross J Jr (1979) Temporal response of left ventricular performance to mitral valve surgery. Circulation 59(6):1218–1231
Stevenson LW, Fowler MB, Schroeder JS, Stevenson WG, Dracup KA, Fond V (1987) Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J of Medicine 83(5):871–876
Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321(26):1828–1830
Tavazzi L (1997) Epidemiology of dilated cardiomyopathy: a still undetermined entity. Eur Heart J 18(1):4–6
Tischler MD, Cooper KA, Rowen M, LeWinter MM (1994) Myocardial function/ valvular heart disease/hypertensive heart disease: mitral valve replacement versus mitral valve repair: a Doppler and quantitative stress echocardiographic study. Circulation 89(1):132–137
Torre-Amione G (1999) The syndrome of heart failure: emerging concepts in the understanding of its pathogenesis and treatment. Current Opinion in Cardiology 14:193–195
Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27(5):1201–1206
Torre-Amione G, Kapadia S, Lee, J, Durand JB, Bies R, Young JB, Mann DL (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93(4):704–711
Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Nat Acad Sci 89(11):4845–4849
Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, Sonnenblick EH (1979) Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Circulation 60(1):170–176
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bolling, S.F., Smolens, I.A. (2000). Mitral Valve repair for surgical remodeling. In: Brett, W., Todorov, A., Pfisterer, M., Zerkowski, HR. (eds) Surgical Remodeling in Heart Failure. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57705-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-57705-5_8
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1223-8
Online ISBN: 978-3-642-57705-5
eBook Packages: Springer Book Archive